Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and ColoradomedRxiv · 2026-08-12Psilocybin Recovery Intervention for Stopping Methamphetamine UseClinicalTrials.gov · 2026-08-11A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsClinicalTrials.gov · 2026-08-10Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networksNature Communications · 2026-08-03A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.Journal of psychopharmacology (Oxford, England) · 2026-08-01PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorderNeuropsychopharmacology · 2026-07-07Raman Activity Investigation and Utilization of PsilocybinJournal of Raman Spectroscopy · 2026-07-01Three cases of wood-lover paralysis: clinical insights from Victoria, Australia.Clinical toxicology (Philadelphia, Pa.) · 2026-07-01Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy SubjectsClinicalTrials.gov · 2026-06-25Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-17Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot TrialClinicalTrials.gov · 2026-05-22Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-15Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner ViolenceClinicalTrials.gov · 2026-05-14Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-14Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based SampleClinicalTrials.gov · 2026-05-12The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-08Human brain changes after first psilocybin useNature Communications · 2026-05-05Evaluating the evidence for repressed memory recovery in psychedelic contextsPsychopharmacology · 2026-04-28Psilocybin-Enhanced Psychotherapy for Methamphetamine Use DisorderClinicalTrials.gov · 2026-04-22Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”PsyArXiv · 2026-03-30Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.CNS drugs · 2026-03-01Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23Pharmacodynamic biomarker - or psychotherapeutic process? Comment on "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression".Journal of affective disorders · 2026-02-01Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model.ACS chemical neuroscience · 2026-01-21Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility StudyClinicalTrials.gov · 2025-12-04A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced CancerClinicalTrials.gov · 2025-12-04Questioning the recovery of dissociated traumatic memories under psilocybin: comment on "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa".Journal of eating disorders · 2025-12-04Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy HumansClinicalTrials.gov · 2025-11-19Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive DisorderClinicalTrials.gov · 2025-11-05A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From MethamphetamineClinicalTrials.gov · 2025-10-07Psychedelics and autobiographical memory - six open questions.Psychopharmacology · 2025-10-01Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics · 2025-07-31Mycelium Growth and Development of spp. Mother Cultures on Agar-Based Media.Journal of fungi (Basel, Switzerland) · 2025-06-13The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.Cureus · 2025-06-01Psilocybin in Alcohol Use Disorder With Comorbid DepressionClinicalTrials.gov · 2025-03-19Psychedelics and autobiographical memory - Six open questionsPsyArXiv · 2025-03-11Psychedelics and autobiographical memory - Six open questionsPsyArXiv · 2025-03-11Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy SubjectsClinicalTrials.gov · 2025-03-05A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major DepressionClinicalTrials.gov · 2025-01-20Age- and estrous-dependent effects of psilocybin in ratsbioRxiv · 2025-01-14Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care.Palliative medicine reports · 2025-01-01Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related DementiaAlzheimer s & Dementia · 2024-12-01Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative MechanismsClinicalTrials.gov · 2024-10-24Human brain changes after first psilocybin usebioRxiv · 2024-10-14Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study.Palliative & supportive care · 2024-10-01Psychedelic use and psychological flexibility: The role of meaningful intention and decenteringJournal of Psychedelic Studies · 2024-08-16Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-24Psilocybin as a Treatment for Anorexia Nervosa: A Pilot StudyClinicalTrials.gov · 2024-06-17Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.Ageing research reviews · 2024-04-01Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.Scientific reports · 2024-02-05Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.Palliative medicine · 2024-02-01Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority TrialResearch Square · 2024-01-04Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Neuroscience applied · 2024-01-01Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.Headache · 2024-01-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.Wellcome open research · 2024-01-01Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samplesJournal of Analytical Toxicology · 2023-12-12A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.Biotechnology advances · 2023-12-01Is psilocybin effective for treatment of depression?Evidence-Based Practice · 2023-10-19Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study IClinicalTrials.gov · 2023-10-12Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and FutureGeorgetown Scientific Research Journal · 2023-10-10Comparison of fragrance and flavor components in non-psilocybin and psilocybin mushrooms using vacuum-assisted headspace high-capacity solid-phase microextraction and gas chromatography-mass spectrometryAdvances in Sample Preparation · 2023-09-02Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.Cureus · 2023-09-01The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24Predictors of Medical Students' Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice.Cureus · 2023-04-01The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10Mescaline: The forgotten psychedelic.Neuropharmacology · 2023-01-01Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users.Journal of psychoactive drugs · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.Journal of psychopharmacology (Oxford, England) · 2022-10-01Psychedelics hold promise for primary care researchFamily Practice · 2022-01-24P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-12-01Psilocybin in the treatment of anorexia nervosa: The English transition of a French 1959 case studyAnnales Médico-psychologiques revue psychiatrique · 2021-09-28Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of clinical psychopharmacology · 2021-01-01Self-reported negative outcomes of psilocybin users: A quantitative textual analysis.PloS one · 2020-01-01Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.Journal of psychoactive drugs · 2020-01-01These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstopAccess Science · 2019-01-01Psychopharmacology of Psilocybin in Cancer PatientsClinicalTrials.gov · 2018-07-19Analysis of Psilocin, Bufotenine and LSD in HairJournal of Analytical Toxicology · 2015-03-01Synthesis, hydrolysis and stability of psilocin glucuronideForensic Science International · 2014-04-01Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MSInternational Journal of Legal Medicine · 2013-05-01Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.PloS one · 2013-01-01A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stabilityInternational Journal of Legal Medicine · 2012-11-01Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbitUA Campus Repository (The University of Arizona) · 1976-12-31Hallucinogenic Mushrooms Including Chemical Hallucinogens: Bufotenin and Psilocybin; a Select Bibliography.Defense Technical Information Center (DTIC) · 1975-11-01ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART21, ON THE PROOF OF STRUCTURE OF THE SULFUR ISOSTERE OF PSILOCINChemischer Informationsdienst · 1974-07-16Benzo[b]thiophene derivatives. XXI. On the proof of structure of the sulfur isostere of psilocinJournal of Heterocyclic Chemistry · 1973-12-01ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART19, THE SULFUR ISOSTERES OF PSILOCIN AND RELATED ISOMERSChemischer Informationsdienst · 1973-11-05Serotonin-like and antiserotonin properties of psilocybin and psilocin.Science (New York, N.Y.) · 1962-06-01